Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–4 of 4 results
Advanced filters: Author: Homie Razavi Clear advanced filters

  • More than 250 million people worldwide are chronically infected with the hepatitis B virus (HBV). In this Comment, members of the International Coalition to Eliminate HBV appraise the current policy environment and the need for appropriate cure research and preparedness to complement the WHO global elimination strategy, the HBV vaccine and the well-tolerated but poorly accessed therapy.

    • Jeffrey V. Lazarus
    • Timothy Block
    • Benjamin C. Cowie
    Comments & Opinion
    Nature Reviews Gastroenterology & Hepatology
    Volume: 15, P: 517-518

  • Increased funding for hepatitis C virus (HCV) research and care delivery is needed to support effective programs for vulnerable communities and meet the WHO 2030 targets for HCV elimination. Strategic collaborations among industry and non-industry stakeholders can address this need. Establishing clear expectations, transparency, and investigator independence in these partnerships can enhance and accelerate HCV elimination efforts. Similar collaborative partnerships can be extended to address challenges in other therapeutic areas.

    • Nancy Reau
    • Jeffrey V. Lazarus
    • Homie Razavi
    Comments & OpinionOpen Access
    npj Gut and Liver
    Volume: 2, P: 1-6

  • Hepatitis C virus infection can cause acute and chronic hepatitis C, which are both characterized by inflammation of the liver. In this Primer, Manns et al. describe the latest developments against the global hepatitis C epidemic in the era of highly effective therapies.

    • Michael P. Manns
    • Maria Buti
    • Zobair Younossi
    Reviews
    Nature Reviews Disease Primers
    Volume: 3, P: 1-19

  • Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease with a substantial burden worldwide. In this Consensus Statement, a global multidisciplinary group of experts develop consensus statements and recommendations addressing a broad range of topics on NAFLD to raise awareness and spur action.

    • Jeffrey V. Lazarus
    • Henry E. Mark
    • Ming-Hua Zheng
    Reviews
    Nature Reviews Gastroenterology & Hepatology
    Volume: 19, P: 60-78